Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.530
+0.016 (3.20%)
Nov 21, 2024, 12:27 PM EST - Market open
Passage Bio Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Passage Bio stock has a target of 13, which predicts an increase of 2,352.83% from the current stock price of 0.53.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Passage Bio is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +2,352.83% | Nov 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +2,352.83% | May 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +2,541.51% | Mar 5, 2024 |
| Raymond James | Raymond James | Buy Maintains $9 → $5 | Buy | Maintains | $9 → $5 | +843.40% | Nov 14, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +1,598.11% | Aug 8, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.90
from -1.86
EPS Next Year
-0.51
from -0.90
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 1.7M | ||
| Avg | n/a | n/a | 543,997 | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.61 | -0.32 | -0.29 | ||
| Avg | -0.90 | -0.51 | -0.47 | ||
| Low | -1.06 | -0.67 | -0.63 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.